
Psychedelic Therapies: Current Research and Applications
Analyze the role of psychedelics in therapy, research advancements, and their clinical usage.
What has been corrected on this page?
Every accepted correction to this page is recorded with the exact change, so readers can see how the page improved over time.
-
DEA emergency-scheduled MDMA into Schedule I in 1985, the year before MAPS was founded in 1986, so MAPS came one year after, not before.
BeforeRick Doblin founded MAPS in 1986, one year before the DEA emergency-scheduled MDMA
AfterRick Doblin founded MAPS in 1986, one year after the DEA emergency-scheduled MDMA
Why: Corrected the sequencing of events: the DEA emergency-scheduled MDMA into Schedule I in 1985, one year before MAPS was founded in 1986, not after. Verified fully applied, no stale mentions remain.
View the full record →
Who checked this page?
1 contributor has checked "Psychedelic Therapies: Current Research and Applications" on When Notes Fly. Each name below links to that person's public CitePep profile, where every contribution they have made is listed with the exact change they proposed.